Anticoagulants essential

In Vitro Anticoagulants. A number of substances have been identified that prevent coagulation of the blood when it is removed from the vascular compartment of the body. Most of these substances remove a vital constituent of the blood that is essential in the mediation of transformation of hquid blood into a soHd. 

Venous thrombectomy may be performed to remove a massive obstructive thrombus in a patient with significant iliofemoral venous thrombosis, particularly if the patient is either not a candidate for or has not responded to thrombolysis. Full-dose anticoagulation therapy is essential during the entire operative and postoperative period. These patients need indefinite oral anticoagulation therapy targeted to an INR of 2.5 (range 2.0 to 3.0). 

It was also essential to determine how effective bromethalin was against warfarin-resistant rats and mice. Such animals, whose resistance to anticoagulants had been determined by World Health Organization tests,(17) were subjected to a standard EPA choice feeding efficacy test with bromethalin at 0.005% in the treated diet. The results indicate (Appendix 6) that 90% of the animals were killed and that consumption patterns were similar to those observed in other choice tests. 

The physiological role of vitamin K is in blood clotting and is essential for the synthesis of at least four of the proteins (including prothrombin) involved in this process. Vitamin K also plays a role in the synthesis of a protein (osteocalcin) in bone. Vitamin K deficiency is rare but can result from impaired absorption of fat. Vitamin K levels in the body are also reduced if the intestinal flora is killed (e.g. by antibiotics). Vitamin K toxicity is rare but can be caused by excessive intake of vitamin K supplements. Symptoms include erythrocyte haemolysis, jaundice, brain damage and reduced effectiveness of anticoagulants. 

---